Test Price
2,800 AED✅ Home Collection Available
KIF1A‑Related Intellectual Disability (MRD9) Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 Accredited Processing and wet‑lab validation.
- ✓ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- ✓ Clinical Guidance: Telephonic Post-Test Genetic Counselling with a DHA-licensed Consultant Medical Geneticist.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
KIF1A‑Related Intellectual Disability (MRD9) is an autosomal dominant neurodevelopmental disorder caused by heterozygous mutations in the KIF1A gene. This NGS test sequences the entire coding region to detect single nucleotide variants, small indels, and copy number variations (CNVs) with high sensitivity. The test is essential for confirming clinical suspicion, guiding prognosis, and enabling accurate genetic counselling.
| Feature | DNA Labs UAE | Alternative Providers |
|---|---|---|
| Methodology | NGS – Full gene sequencing + CNV analysis (Illumina NovaSeq, 100X coverage) | Sanger sequencing of selected exons only |
| Turnaround Time | 3–4 Weeks | 5–7 Weeks (multi‑step reflex) |
| Accreditation | DHA Licensed (Facility 1143), ISO 15189 | Variable; may not meet UAE mandated standards |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
"A positive result for a KIF1A variant must always be interpreted within the full clinical and familial context. While some missense variants correlate with milder phenotypes such as isolated learning difficulties, severe truncating mutations frequently lead to early‑onset spastic paraplegia and profound intellectual disability. This NGS assay provides the molecular confirmation required for accurate diagnosis, though it should never replace a thorough neurological examination and detailed family pedigree analysis."
Advisory: Medication and Treatment Continuity
⚠ Important Medication Warning
Do not discontinue or alter prescribed medications without consulting your treating physician. Anti‑epileptic drugs, muscle relaxants, or behavioural therapies should be maintained unchanged unless explicitly advised by your neurologist or genetic counsellor following test results.
Exclusion Criteria & Emergency Red Flags
- This test is not indicated as a standalone screening tool in asymptomatic individuals without a documented family history or clinical signs suggestive of MRD9.
- Individuals with an active febrile illness or acute neurological decompensation must be clinically stabilised before sample collection proceeds.
- Patients currently undergoing chemotherapeutic regimens that affect DNA integrity should postpone sample collection by at least 4 weeks unless a buccal swab alternative is pre-approved by the laboratory.
- Emergency red flags: sudden loss of ambulation, intractable seizures, or signs of raised intracranial pressure warrant immediate emergency department attendance – do not delay care while waiting for genetic results.
Patient FAQ & Clinical Guidance
1. What does the KIF1A genetic test detect, and what is its accuracy?
A: This test sequences the entire KIF1A gene using next‑generation sequencing to identify disease‑causing single nucleotide variants, small insertions/deletions, and copy number variations. It delivers over 99.9% analytical sensitivity and specificity when validated by orthogonal methods such as Sanger sequencing or MLPA.
2. How is the sample collected, and is home collection available?
A: Sample collection requires 3–5 mL of peripheral whole blood or a few drops on an FTA card. Yes, we offer a VIP Mobile Phlebotomy service available daily from 8 AM to 11 PM, ensuring cold‑chain transport of the specimen to our ISO 15189 accredited laboratory.
3. Is genetic counselling included, and how is my data protected under UAE law?
A: Yes, a pre‑test genetic counselling session is included to construct a detailed pedigree and discuss the implications of potential results. Your genetic data is strictly protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
This service operates in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Our diagnostic protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring patient safety and informed consent are prioritised at every stage.
DNA Labs UAE is fully licensed by the Dubai Health Authority (DHA) under Facility License Number 1143. We maintain ISO 15189 accreditation for our molecular genetics laboratory, guaranteeing the highest standards of quality and reliability for all genetic testing services.
Clinical & Logistical Metadata
| Test Name | KIF1A‑Related Intellectual Disability (MRD9) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (FTA Card or Venous Blood Draw) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Gene Sequencing + CNV Analysis |
| ICD-10-CM Code | Q87.8 (Other specified congenital malformation syndromes involving early-onset intellectual disability) |
| LOINC Code | 82367-7 (Gene mutations found in the Hereditary intellectual disability panel in Blood or Tissue by Sequencing) |
| DHA Facility License & Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | License No: 1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians